MiNK Therapeutics, Inc. (INKT:NASDAQ) closed at $10.71 on October 23, 2026, up 6.46% on the day. The stock trades 36.7% below its 52-week high of $16.93 and 26.3% above its 52-week low of $8.48. Over the past year, it lost 28.5%. MiNK Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, INKT closed higher on 112 days (44%). Its best day was March 10, 2026 (+29.28%) and its worst was March 11, 2026 (-17.25%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 2 times.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening illnesses.
Find more stocks like INKT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.